Protease Inhibitor Cocktail: K1019 Workflow Guide
2026-08-17
Learn how Protease Inhibitor Cocktail (100X in DMSO, EDTA plus), SKU K1019, supports protein degradation prevention in viability, proliferation, cytotoxicity, Western blot, and co-immunoprecipitation workflows. This scenario-based guide explains compatibility, protocol parameters, data interpretation, and practical vendor-selection considerations.
AG-126 (Tyrphostin AG-126) Assay Guide
2026-08-17
This scenario-based guide explains how AG-126 (Tyrphostin AG-126), SKU C4338, can help researchers interpret ERK-dependent changes in viability, proliferation, and inflammatory readouts without confusing pathway inhibition with nonspecific cytotoxicity. It covers concentration design, solvent controls, fresh-solution handling, cross-domain interpretation, and practical product-selection criteria.
NF 449: A Selective Purinergic Receptor Antagonist
2026-08-16
NF 449 is a high-potency purinergic receptor antagonist for separating ATP-driven P2X1 signaling from broader platelet responses. This practical guide connects receptor pharmacology with collagen-induced platelet aggregation, calcium flux, thrombus models, and assay troubleshooting.
Dextran sulfate sodium salt: DSS Colitis Workflow
2026-08-15
Build a reproducible intestinal inflammation model with Dextran sulfate sodium salt and connect epithelial injury to repair biology. This workflow combines practical DSS handling, recovery-phase sampling, and GPR35-KLF5 pathway readouts for ulcerative colitis research and therapeutic screening.
Flumequine Workflows for Topoisomerase II Research
2026-08-15
Flumequine provides a defined small-molecule perturbation for linking topoisomerase II inhibition with replication, DNA damage, and cancer-cell response assays. A two-axis viability strategy helps distinguish growth arrest from true cell killing, improving interpretation of concentration- and time-dependent results.
Dimethyloxalylglycine (DMOG): Practical Guide
2026-08-14
Dimethyloxalylglycine (DMOG), SKU A4506, provides a cell-permeable way to investigate hypoxia-inducible factor stabilization and related oxygen-sensing responses under controlled laboratory conditions. This guide covers preparation, assay controls, solubility, storage, and interpretation; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or medical applications.
Chlorin e6 (Ce6): Reliable PDT Assays
2026-08-14
This scenario-driven guide shows how Chlorin e6 (Ce6), SKU B8314, can help researchers standardize photosensitizer handling, light exposure, controls, and cytotoxicity interpretation. It connects product specifications with published anticancer and antibacterial photodynamic therapy evidence while distinguishing literature-supported parameters from practical assay recommendations.
Cannabis Terpenes Relieve Neuropathic Pain via A2A
2026-08-13
Schwarz et al. show that five Cannabis sativa terpenes produce robust antinociception in mouse models of chemotherapy-induced peripheral neuropathy and inflammatory pain through adenosine A2A receptor signaling. Pharmacological blockade, spinal CRISPR knockdown, functional assays, receptor binding, and computational modeling together provide a mechanistic framework for developing non-rewarding terpene-based analgesic strategies.
Fluoxetine HCl in Reliable Cell Assays
2026-08-13
Learn how Fluoxetine HCl, SKU A2436, can improve experimental control in serotonergic cell-based viability, proliferation, and receptor assays. This scenario-driven guide covers solubility, vehicle controls, storage, assay interpretation, and practical vendor-selection criteria.
Moxidectin–Polyene Synergy in Oral Candidiasis
2026-08-12
A 2024 study found that Moxidectin, a macrocyclic lactone anthelmintic, potentiates amphotericin B and nystatin against Candida albicans by increasing fungal ergosterol biosynthesis. Genetic, biochemical, and mouse-model data support an ergosterol-dependent mechanism, while the findings remain preclinical and require further pharmacological validation.
Otilonium Bromide: Mechanism and Research Uses
2026-08-12
Otilonium Bromide is a quaternary ammonium antimuscarinic agent used to investigate cholinergic signaling and smooth muscle pharmacology. Product documentation describes high purity, multiple solvent options, and a 10 mM DMSO formulation, while current evidence does not support treating it as an antiviral NSP15 inhibitor.
Cx43/NF-κB Signaling Drives AngII Macrophage Polarization
2026-08-11
The reference study identifies connexin 43 (Cx43) and NF-κB p65 as functionally connected regulators of angiotensin II–induced M1 macrophage polarization in RAW264.7 cells. Its inhibitor-based design links Cx43 activity with inflammatory marker expression, while also highlighting the need to distinguish channel-specific effects from broader Cx43 signaling in future cardiovascular studies.
NADH: Redox Control and Mechanistic Assays
2026-08-10
NADH is more than an energy-metabolism cofactor: it is an experimentally useful redox variable. This guide explains how reduced nicotinamide adenine dinucleotide can be used to distinguish metabolic correlation from mechanism across mitochondrial, disease-model, and photocatalytic workflows.
Morin: From Mechanism to Translational Strategy
2026-08-09
Morin offers translational researchers a dual opportunity: mechanistic interrogation of oxidative, inflammatory, and mitochondrial biology, plus fluorescent aluminum detection. This article connects podocyte and neurobiology workflows with clinical lessons from a prochlorperazine-associated neuroleptic malignant syndrome case while clearly separating evidence from hypothesis.
Cabozantinib in RCC: Workflow and Troubleshooting
2026-08-08
Build reproducible Cabozantinib and XL184 experiments around exposure time, phosphosite remodeling, angiogenesis, and tumor-cell motility. This workflow separates acute pathway suppression from chronic adaptation so RCC, endothelial, and RET-focused assays produce interpretable results.
457 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page